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extent, and to me it emphasizes the importance of
beginning this treatment at the earliest stage possible.
In Case 5 it will be observed that treatment was not
begun until six days after the initial attack and four
days after she became paralyzed, but certain measures
had been taken before I saw her which I believe aided
the hyperemic action.
I do not presume to hold that this treatment
will cure all cases of infantile paralysis no matter
in which stage it may be applied, but I strongly
believe that if it is applied before the fourth day of
the attack it will in many instances prevent a
paralysis resulting, and in the majority of cases
at least insure a useful and serviceable limb.
ACTINOMYCOSIS TREATED WITH
VACCINES
BY ROGER KINNICUTT, M.D., WORCESTER, MASS.,
AND
W. J. MIXTER, M.D., BOSTON.
(From the Pathologic Laboratory of the Massachusetts GeneralHospital.)
AcTiNOMYcosis, as described by Dr. J. H.
Wright, is a definite process characterized by
destruction of tissue and abscess formation, and
by an excessive formation of connective tissue,
caused by a specific organism, the actinomyces
bovis. A complete review of the whole subject,
written by him, is to be found in Osier's " ModernMedicine." The micro-organism causing the dis-
ease is an anerobe, and from pure cultures of this
organism alone we have made our vaccines.
Actinomycosis appears usually about the head
and neck, probably in 50% of all cases, and of the
remainder 20% are abdominal and 15% thoracic.
In the cervico-facial type the mortality is prob-
ably from 25% to 40%. In the thoracic type
the prognosis is very bad, only five or six recover-
ies being reported. The abdominal type is a little
less grave, having a mortality of 70% to 80%,
and the cases that recover are always those in
which the infection is pretty sharply defined and
localized.
The treatment up to the present time has con-
sisted of excision or curetting where possible,
followed by the use of copper sulphate both in-
ternally and locally, and large doses of iodide of
potash. In going over the literature, we havebeen able to find only four cases of so-called
actinomycosis which were treated by the use of
vaccines. Winn reports a thoracic case in which
an abscess of the lung and liver existed. He says :
"It is now admitted, there are many forms of
actinomycosis, and the significance of the term
has been widened to include a class of diseases
caused by a distinct species of parasites. Twogeneric names for this organism are in use,
viz., streptothrix and actinomyces. The former
name is accepted by British and most American
investigators, while the latter is still in use on
the continent."
This, and the description of the organism and
its cultural characteristics, particularly the fact
that it was not an anerobe, leads us to believe that
it does not conform to the description as laid
down by Wright, or, in other words, is not
actinomyces according to the best usage of the
term, but rather a streptothrix. Winn made his
vaccine from surface agar cultures, taken directly
from the pus without attempting to obtain the
organism in pure culture. These cultures were
dried at 60° for one hour, and the dried surface
growth scraped off. This dried substance he
called " actinomycotin." The patient received
six doses of .001 mgm. of this actinomycotin in
all, showed a rise in opsonic index after inocula-
tion and made a complete recovery in three
months.
Whittier, in April, 1909, at the meeting of the
American Association of Pathologists and Bac-
teriologists, reported a case of a growth at the
angle of the ribs on the left side. An operation
was performed and actinomyces found. A vac-
cine was made from surface growths or bouillon,
and there was no attempt made to obtain the
organism pure. He also stated that his dosage
was from fifty to one hundred million. Because
of the character of the growth of true actinomyces
in bouillon, it is impossible to standardize vac-
cines, except in a very rough way. It seems prob-
able that in this case also we may be dealing with
streptothricosis, or if actinomycosis, that the
cultural growth was some secondary infection and
not actinomyces.
Harbitz and Grondahl have studied the subject
very thoroughly in Norway. The organism which
they have accepted as the causative factor con-
forms very closely with Wright's description.
They used a pure culture vaccine on two cases,
with recovery in one and death in the other.
Although it is veryhard to judge, it seems probable
that the vaccine was very much less concentrated
than the one which we have used. They report
no general reaction, whereas we have found that
both general and local reaction might be obtained
often with a rather small dose.
METHOD OF PREPARATION OF VACCINE.
Pure cultures are obtained by thoroughly wash-
ing separate granules gotten from the pus in five
or six changes of sterile, normal salt solution.
This is necessary because of the usual secondary
infection accompanying the disease. In many
cases the secondarily invading bacteria are so
numerous and so intimately mixed with the fila-
ments of the granule that it is impossible to obtain
the actinomyces in pure culture; but as we have
found that the stock vaccine is apparently as
effective as an autogenous one, when the organ-
ism has once been obtained in pure culture, it can
be left growing in the laboratory to be used when
needed.
After a number of granules have been thor-
oughly washed, each one is placed in the bottom
of a tube of melted glucose agar at a temperature
of about 45° C.
Some may be broken up on the side of the tube,
thus scattering the filament through the medium
in the hope of obtaining single, isolated colonies;
and others, if the secondary infection is not too
marked, may be planted whole.
Colonies of actinomyces as a rule do not begin to
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show any growth until after forty-eight hours or
more at 37° C. When a fine growth is obtained, the
single colonies are cut out of the solid medium
and transferred to tubes of plain bouillon in the
bottoms of which they grow as single, irregular,granular, white, yellow or occasionally brownish-
black colonies, with no clouding of the bouillon.
For a vaccine, at least a dozen bouillon tubes
should be inoculated, and the colonies transferred
to fresh bouillon tubes at least every four days.
After a week or ten days, the colonies attain a
moderate size and are then transferred to a sterile
test tube, preferably made of thick glass, in which
they are ground up as much as possible. This is
most easily done by means of a sterile glass rod
over one end of which has been slipped an ordinary
rubber nipple. To the ground-up colonies is added
a little normal salt solution. The test tube is
then drawn out, sealed in the ordinary way, and
kept in a water bath at 60° C. for one hour.
After sterilization, the contents of the tube are
transferred to a bottle containing 50 ccm. of
sterile normal salt solution and 1 : 400 lysol or
carbolic acid, the bottle being covered with a
sterile rubber cap.
It is impossible to standardize such a vaccine
except in a very rough way, because the filaments
composing the colonies are not evenly broken up.
We have used test tubes of approximately the
same caliber, filled them for a definite distance
with the actinomyces colonies, and added a defi-
nite amount of sterile salt solution. Because of
the inability to determine the strength of the
vaccines, and as it was found that large doses
might cause a marked general reaction, treatment
was always begun with very small doses, which
were generally increased in strength.
The routine method of treatment is to give
0.1 ccm. of the " vaccine " subcutaneously for
the first dose. This is repeated every three or
four days, increasing the amount given 0.05-
0.1 ccm. each time until a dosage of 0.75 ccm.
has been reached. A greater amount than this
we have only given in one case, when we ran the
dosage up to 4 ccm., but with no evident benefit,
although the constitutional symptoms were quite
severe. Of course, as in all abscesses, if there
are any collections of pus, incisions should be
made and drainage established.
We have treated or had treated with " vac-
cines " eight cases of actinomycosis, two with
abdominal, two with pulmonary, and four with
cervico-facial actinomycosis. The thoracic cases
were all advanced when first seen, both showing
actinomycotic lesion of the chest wall, and one of
them a large indurated area containing pus pockets
over one side of the neck. Both these cases grew
rapidly worse and died. A vesy interesting result
of the use of the vaccine was the immediate large
increase of actinomycotic granules in the sputum.
This effect lasted several days.
Of the two abdominal cases, one, after operation
and drainage of a large abscess in the left inguinal
region, followed by treatment with " vaccine "
for two months, has apparently made a complete
recovery. The other case was operated upon
Nov. 19, 1908, for appendicitis, and an abscess
containing actinomycotic granules found. Since
March 14, 1909, the patient has been given auto-
genous actinomyces " vaccine " off and on up to
three months ago, when she died following in-
volvement of the lungs. There were periods of
apparent improvement, but the results on the
whole were not striking, except for the fact that
the general reaction was very marked with largedoses, and that the patient, before vaccine treat-
ment was begun, was growing worse so rapidly,
and the process spreading so fast, that a fatal
termination seemed certain in a short time. There
was marked improvement at first under vaccine
treatment, although at the same time the use of
iodides and copper sulphate was stopped.
Of the four cases of actinomycosis of the jaw"
and neck, three have apparently completely re-
covered, and one is rapidly improving under that
treatment. The improvement in one of these
cases was particularly striking. When admitted
to the hospital, he had been suffering from ac-
tinomycosis of the jaw for over six months, had
been treated thoroughly with iodide of potash,
and had had numerous small abscesses which had
formed, opened and curetted, but in spite of this,
the induration had extended down his neck below
the clavicle and a short distance beyond the
median line to the other side. He was given
actinomyces vaccine subcutaneously, and all other
treatment omitted. A few days after the first
injection, two small fluctuating areas appeared in
the neck which were opened and found to contain
pus loaded with actinomyces granules, and no
other micro-organisms. After this the lesion
rapidly softened and diminished in size, and at the
end of a month and a half all induration had dis-
appeared. He was given vaccine every three or
four days for about three months, and, at the
present time, a little over a year after treatment
was begun, he is perfectly well and shows no
evidence of the disease except for two small scars,
the remains of incision made in opening abscesses.
In cases of actinomycosis of the jaw, the start-ing point is usually a bad tooth, so, of course, the
offending tooth should be removed. It is im-
possible to draw any general conclusion from these
few cases, but it does seem that the use of vac-
cines in superficial actinomycosis does do good.
In lung actinomycosis with the severe secondaryinfection which invariably accompanies it, vac-
cines are apparently useless.
-a-.
Clinical Department
THREE CASES OF PELLAGRA
BY C. H. DEAN, M.D., NORTHAMPTON, MASS.
Since seeing the case of pellagra reported in the
Boston Medical and Surgical Journal of
Sept. 7, 1911, I have seen three other cases, mak-
ing a group of four. Three of this group were in
the Northampton State Hospital. The geo-graphical distribution, however, shows that this
is by no means a pellagrous center. One case
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